Ocular toxoplasmosis

被引:0
|
作者
Pleyer, U.
Torun, N.
Liesenfeld, O.
机构
[1] Charite Med Berlin, Campus Virchow Klinikum, Augenklin, D-13353 Berlin, Germany
[2] Charite Med Berlin, Inst Mikrobiol & Hyg, Toxoplasmose Beratungslabor Bereich Ost Deutschla, D-13353 Berlin, Germany
来源
OPHTHALMOLOGE | 2007年 / 104卷 / 07期
关键词
intraocular inflammation; retinochoroiditis; Toxoplasma gondii; uveitis;
D O I
10.1007/s00347-007-1535-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Toxoplasmosis is a parasitic zoonosis which occurs worldwide and is an important cause of blindness. The infection is naturally acquired by the ingestion of oocysts excreted by infected cats or by ingestion of tissue cysts in undercooked or raw meat. Primary infection during pregnancy may result in a congenital infection. Toxoplasmic retinochoroiditis is the most common cause of posterior uveitis in immunocompetent patients. Depending on the patient's age, ocular symptoms vary presenting with reduced visual acuity, strabismus, and nystagmus in young children - in adults decreased vision and floaters are most frequently reported. Active toxoplasmic retinochoroiditis typically presents as grey-white retinal necrosis with choroiditis, vasculitis and vitritis. However, atypical presentations including neuroretinitis, papillitis, Fuchs-like anterior uveitis, scleritis and acute retinal necrosis have been described. The diagnosis is based on clinical findings and can be supported by the detection of antibodies and Toxoplasma gondii DNA. Toxoplasmosis therapy includes antimicrobial drugs and corticosteroids. There are several regimens with different drug combinations including, among others, pyrimethamine, sulfadiazine, clindamycin, and trimethoprim-sulfamethoxazol. The prognosis for ocular toxoplasmosis is favorable in immunocompetent individuals, as long as the central macula is not directly involved. The present article reviews the epidemiology, pathogenesis, clinical presentation and management of toxoplasmic retinochoroiditis.
引用
收藏
页码:603 / 615
页数:13
相关论文
共 50 条
  • [1] OCULAR TOXOPLASMOSIS
    DRELL, MJ
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1945, 28 (05) : 542 - 543
  • [2] Ocular toxoplasmosis
    Bacsal, Kristine
    Chee, Soon-Phaik
    OPHTHALMOLOGY, 2007, 114 (03) : 616 - 617
  • [3] OCULAR TOXOPLASMOSIS
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 173 (08): : 915 - 915
  • [4] Ocular toxoplasmosis
    Karambelkar, R. P.
    Karambelkar, G. R.
    INDIAN PEDIATRICS, 2013, 50 (02) : 257 - 257
  • [5] OCULAR TOXOPLASMOSIS
    JABS, DA
    INTERNATIONAL OPHTHALMOLOGY CLINICS, 1990, 30 (04) : 264 - 270
  • [6] OCULAR TOXOPLASMOSIS
    HANDLER, RP
    ANNALS OF INTERNAL MEDICINE, 1979, 91 (02) : 324 - 324
  • [7] Ocular toxoplasmosis
    R. P. Karambelkar
    G. R. Karambelkar
    Indian Pediatrics, 2013, 50 : 257 - 257
  • [8] OCULAR TOXOPLASMOSIS
    OCONNOR, GR
    ACTA OPHTHALMOLOGICA, 1984, : 69 - 70
  • [9] OCULAR TOXOPLASMOSIS
    TABBARA, KF
    INTERNATIONAL OPHTHALMOLOGY, 1990, 14 (5-6) : 349 - 351
  • [10] Ocular Toxoplasmosis
    Goh, Eunice Jin Hui
    Putera, Ikhwanuliman
    Nora, Rina La Distia
    Mahendradas, Padmamalini
    Biswas, Jyotirmay
    Chee, Soon-Phaik
    Testi, Ilaria
    Pavesio, Carlos E.
    Curi, Andre Luiz Land
    Vasconcelos-Santos, Daniel Vitor
    Arora, Atul
    Gupta, Vishali
    de-la-Torre, Alejandra
    Agrawal, Rupesh
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (07) : 1342 - 1361